CagriSema is a combination therapy that includes Cagrilintide, an amylin analog, and Semaglutide. Amylin is a hormone co-secreted with insulin that helps regulate glucose levels and suppress appetite. Cagrilintide mimics amylin’s effects, enhancing satiety and reducing food intake. By combining Cagrilintide with Semaglutide, CagriSema, researchers aim to provide a more rapid and comprehensive approach to menopausal fat belly loss by targeting multiple pathways involved in appetite regulation and glucose metabolism.

Our peptides API formulations are FDA registered and not affiliated, endorsed, or intended to replace Eli Lilly, Novo Nordisk, or other companies' FDA-approved brands such as Victoza, Saxenda, Byetta, Ozempic, Rybelsus, Wegovy, Adlyxin, Trulicity, or Mounjaro.

Tirzepatide Pharma White label triple power oral GLP-1 peptides. Each capsule delivers 1mg Cagrillintide Peptide, 3mg of Semaglutide w/ Methyl B12( 100mcg), NAD+ (250mg), and 3mg SNAC Absorption enhancer. The quantity price tiers are 2-pack, 500-pack, 3700-pack, and 5000-pack. Peptides ship in unlabeled cold medium, making it easy for you to apply your labels and resell.

2-30cts